Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Transmedic will be able to distribute the Alba by Quotient portfolio, our range of high-quality reagents, along with the MosaiQ solution, which is currently under development and aims to facilitate fast and accurate test results in the autoimmune diseases and allergy fields.“We are thrilled to collaborate with such a strong partner and to be able to expand our operations in Southeast Asia,” said Khaled Hamed, Quotient’s Head of APAC.To find out more about Transmedic, please visit their website: www.transmedicgroup.com
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
AliveDx Suisse S.A. and Kyungil Hi-tec INC have signed an exclusive distribution agreement, which will enable Kyungil Hi-tec to distribute the MosaiQ® solution in South Korea. The distribution agreement takes effect immediately. This strategic partnership with an important partner in
AliveDx Suisse S.A. and PZ Cormay S.A. have signed a distribution agreement, which will enable PZ Cormay to distribute the MosaiQ® solution in Poland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and presence across
We are excited to announce our participation in the upcoming ADLM 2024 Congress, from July 30 to August 1, 2024, in Chicago, USA. Visit us at booth #4055 to learn more about our high-quality blood bank reagents, and the latest
AliveDx Suisse S.A. and Prolab IVD S.R.L. have signed a distribution agreement, which will enable Prolab to distribute the MosaiQ® solution in Romania. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and
AliveDx Suisse S.A. and BioAnalytica S.A. have signed a distribution agreement, which will enable BioAnalytica to distribute the MosaiQ® solution in Greece and Cyprus. The distribution agreement takes effect immediately. This strategic partnership underscores AliveDx’s commitment to expanding its geographical
AliveDx Suisse S.A. and Axon Lab AG have signed a distribution agreement, which will enable Axon Lab to distribute the MosaiQ® solution in Austria, Germany and Switzerland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.